The Heart and Brain Symposium (HBS) 2018

The Heart and Brain Symposium (HBS) is organized by Kenes Group and will be held during Jun 28 - 30, 2018 at Hyatt Regency McCormick Place, Chicago, Illinois, United States of America.

The target audience for this medical event is intended for physicians, nurses, and other healthcare providers involved with the fields of Cardiology and Neurology. This CME Conference has been approved for a maximum of 19.25 AMA PRA Category 1 Credits.

Conference Description :
The Symposium facilitates an active and highly cooperative style of communication and interaction between prominent cardiologists and neurologists, thus creating favorable conditions for discussion towards a more integrated approach to our patient care.

Highlights will include interactive case studies on complicated patients that require teamwork across the cardiology and neurology departments - including Atrial Fibrillation, PFO, ablation, and occluders - as well as debates on treatment where there is a lack of clear guidelines.

The theme of the event is "Preventing cardioembolic stoke as an interdisciplinary team" which shows the symposium`s special focus on the dialogue between Neurology and Cardiology towards a more integrated approach to our patient care.

Emerging and interesting data is still being accumulated regarding the relationship between the heart and the brain, and vice versa. New therapies continue to be developed, and this symposium will trigger an exchange of innovative ideas, considerable expertise and interdisciplinary working techniques which will help the participants benefit from one another's experience. This is our main goal, and the scientific program is designed to facilitate this exchange of knowledge.

Join us at the Heart and Brain Symposium in the windy city of Chicago, where the winds of change will help us create more interrelated and integral vision of medicine and human health.

• Gain comprehensive knowledge on the management of cardioembolic strokes from the primary to the secondary prevention.
• Better understand how to approach the cases (including co-morbidity) where there is a lack of clear guidelines for the cardiologists and neurologists.
• Know how to work across departments on complicated patients, who have heart and brain conditions, which require decisions on such matters as PFO, ablation and occluders.
• Get the knowledge you need to implement a more integrated approach to patient care at your hospital.
• Present your latest research at a dedicated forum.

Conference Objectives:
After completing this activity, the participant should be better able to:
• Describe advances in the detection of atrial fibrillation.
• Debate stroke risks, prevention and treatment in atrial fibrillation patients.
• Discuss oral anticoagulation, vascular disease and stroke.
• Review Patent Foramen Ovale (PFO) and Stroke.
• Discuss cardioembolic strokes from the primary to the secondary prevention.
• Address the relationship of embolic stroke of undetermined source with atrial fibrillation.
• Discuss clinical trials and treatment options for an embolic stroke of undetermined source.
• Debate the association between cognition and the heart.
• Review clinical cases lacking clear guidelines for cardiologists and neurologists.
• Apply the most current scientific, clinical, diagnostic and therapeutic advances in the management of atrial fibrillation.